PLM60 for Peripheral T Cell Lymphoma (PTCL)

Clinical trial NCT03553914 · WITHDRAWN

Trial details

NCT number: NCT03553914
Sponsor: Conjupro Biotherapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2021-01-01
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.